Skip to main content
. Author manuscript; available in PMC: 2018 Apr 1.
Published in final edited form as: Bone. 2016 Dec 7;97:15–19. doi: 10.1016/j.bone.2016.12.001

Table 2.

Biochemical Analyses

Proband I-1 Proband I-1 I-2 II-1 II-2
Feature At presentation After phosphate treatment Baseline Baseline Baseline
Age, years 54 55 48 21 19
Calcium (8.5 to 10.5 mg/dL) 8.9 9.3 9.3 9.1 9.9
Phosphorus (2.5 – 4.5 mg/dL) 1.7 4.4 4.1 3.8 4.5
1,25(OH)2 D (21 ng/mL to 65 ng/mL) 188.2 63.2 74 57 62
25(OH) D (20–100 ng/mL) 35 43 28 14 11
iPTH (10–65 pg/mL) 18 54 27 34 25
Creatinine (0.5 to 1.0 mg/dL) 1.1 0.6 0.5 0.6
Alkaline Phosphatase (39 – 117 IU/L) 111 54 65 61
24 hour urine calcium 864 402 89 151 80
Urine ca/cr ratio (<0.21 mg2/mg2) 0.64 0.25 0.15 0.15 0.18
TRP (> 90%) 60% 94% 91% 93%
TmP/GFR (Male 45–55 yrs, 0.9–1.35 mmol/L; Female 45–55 yrs, 0.88–1.44; young females 0.96– 1.5) 0.33 1.5 1.2 1.5
Genotype R67H/G191S R67H/WT R67H/WT R67H/G191S